KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Idexx Laboratories (IDXX) Return on Sales (2016 - 2025)

Idexx Laboratories has reported Return on Sales over the past 17 years, most recently at 0.23% for Q4 2025.

  • Quarterly results put Return on Sales at 0.23% for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was 0.25% (up 2.0% YoY), and the annual figure for FY2025 was 0.25%, up 2.0%.
  • Return on Sales for Q4 2025 was 0.23% at Idexx Laboratories, down from 0.25% in the prior quarter.
  • Over the last five years, Return on Sales for IDXX hit a ceiling of 0.26% in Q2 2025 and a floor of 0.15% in Q2 2022.
  • Median Return on Sales over the past 5 years was 0.23% (2022), compared with a mean of 0.23%.
  • Biggest five-year swings in Return on Sales: grew 8bps in 2021 and later dropped -9bps in 2022.
  • Idexx Laboratories' Return on Sales stood at 0.2% in 2021, then grew by 2bps to 0.21% in 2022, then increased by 4bps to 0.22% in 2023, then increased by 5bps to 0.23% in 2024, then rose by 0bps to 0.23% in 2025.
  • The last three reported values for Return on Sales were 0.23% (Q4 2025), 0.25% (Q3 2025), and 0.26% (Q2 2025) per Business Quant data.